Search
for
Sort by
Research 331–360 of 1000+
- Особливості перебігу симптомів нижніх сечових шляхів у чоловіків із доброякісною гіперплазією передміхурової залози та COVID-19
- This month in JAAD International: November 2021: COVID-19 and hair loss
- COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium - The Role of Proteoglycan Replacement Therapy with Nourkrin® in Clinical Treatment of COVID-19 Associated Hair Loss
- Cutaneous manifestations of COVID-19
- Covid-19 in Lupus Nephritis
- Covid-19 in Lupus Nephritis
- Unrecognised underlying condition for COVID-19: perspective study of meridian and M-shaped male baldness
- Telogen effluvium: Long term Covid-19 symptom
- Covid Lines
- Effect of platelet-rich plasma on diffuse efflffluvium in post-COVID-19 infection
- COVID-19: A wake-up call for teledermatology in India
- Surgical Care and Resident Education during COVID-19 Pandemic
- COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium – The Role of Proteoglycan Replacement Therapy with Nourkrin® in Clinical Treatment of COVID-19 Associated Hair Loss
- COVID-19 Clinical Outcomes and Nationality: Results from a Nationwide Registry in Kuwait
- Recommendations on trichological treatments during COVID-19 pandemic
- Co-Relation Between Androgenetic Alopecia and Severity of COVID-19 Disease – A Cross-Sectional Study
- Hospitalized COVID-19 Androgenetic Alopecia JAAD data age group comparison with other references
- Pathological sequelae of long-haul COVID
- Is COVID-19 Gender-sensitive?
- Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study
- Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data
- The COVID-19 Sequelae: A Cross-Sectional Evaluation of Post-recovery Symptoms and the Need for Rehabilitation of COVID-19 Survivors
- Long-COVID Clinical Features and Risk Factors: A Retrospective Analysis of Patients from the STOP-COVID Registry of the PoLoCOV Study
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
- Post‐COVID-19 syndrome: assessment of short- and long-term post-recovery symptoms in recovered cases in Saudi Arabia
- Post-COVID-19 Syndrome Mechanisms, Prevention and Management
- Long COVID syndrome: An unfolding enigma
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients.
- The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19